Replies to post #186721 on Biotech Values

[justrpaul]

Commercial ins HCV Prevalence less than the rest

http://us.milliman.com/insight/2013/Healthcare-reform-and-Hepatitis-C-A-convergence-of-risk-and-opportunity/

The prevalence of HCV is higher in prison populations, Medicaid rolls, Vietnam era veterans, etc. It has to be less somewhere. It is less in commercial (non-governmental) patients. Milliman in the study above estimated a prevalence rate for commercial patients of 0.0047.

25,000,000
*0.0047
117,500 HCV in the exclusive formulary, then you must factor for GT1